Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
InterVenn Biosciences has appointed Alec Ford and Mitch Levine to its Board of Directors as the company advances the commercialization of its glycoproteomic diagnostics.
Sanyou Biopharmaceuticals has released AI-STAL 2.0, an upgraded version of its AI Super-Trillion Antibody Library, which integrates artificial intelligence across the full drug discovery process to enhance molecule generation, optimization, and evaluation.
Ultima Genomics has appointed Francisco De La Vega as Vice President of Germline Genomics and Distinguished Scientific Fellow. He will guide the company’s efforts in inherited genome analysis and expand applications of its sequencing technology for genetic disease research and clinical use.
OMNY Health has expanded its healthcare data ecosystem to include over 175 million de-identified patient records and launched a new oncology product suite designed to close real-world evidence gaps in cancer research.
UNC Greensboro has received a $2 million award from BioMADE to launch NC BioMISSION, a bioindustrial manufacturing training and research program aimed at preparing students for biotechnology careers in North Carolina.
Vortex Imaging has closed a $12 million funding round to support development and regulatory clearance of its computational ultrasound system, while expanding its board with experienced medtech leaders.
SandboxAQ has integrated its Large Quantitative Models with Anthropic’s Claude, enabling users to run complex scientific workflows for drug and materials discovery through natural language prompts.
United Imaging unveiled its complete radiotherapy portfolio at ESTRO 2026 in Stockholm, featuring the CE-marked uRT-linac 506c system with integrated diagnostic CT and adaptive AI-driven treatment capabilities.
Virtual Science AI has launched Medical Competitor AI, a platform that uses artificial intelligence to analyze competitor medical activities and scientific narratives for pharmaceutical companies.
Accuray Incorporated and the University of Wisconsin School of Medicine and Public Health have entered a 10-year research agreement to develop personalized cancer treatments using Accuray's Stellar adaptive radiation therapy platform.
Enlil announced a record first quarter of 2026, signing eight new MedTech customers that migrated from legacy quality and product lifecycle systems to its AI powered traceability platform.
Psynk AI has announced a partnership with Ocean View Psychiatric Hospital to pilot its AI psychiatric assistant in an inpatient setting, supporting documentation, patient assessment, and care coordination.
Orbis International and Siloam Vision have introduced artificial intelligence screening for premature babies in Mongolia to detect retinopathy of prematurity, the leading cause of childhood blindness worldwide.
ELLKAY has appointed Lucky Singh as Chief Technology Officer to lead its technology and AI strategy, focusing on advancing healthcare data interoperability and intelligent automation.
Optura has secured $17.5 million in Series A funding led by Salesforce Ventures, with participation from Echo Health Ventures and others, to expand its ROAI platform for measuring AI investment value in healthcare.
Urologic Health has secured $11 million in seed funding to advance its catheter-free bladder function monitoring system and prepare for U.S. market entry.
InsideTracker has launched Terra, a neurosymbolic AI platform designed to help wellness businesses deliver individualized, evidence-based health guidance at scale. The system integrates multiple health data sources to generate transparent, science-backed recommendations.
Enlil reported a record first quarter of 2026, securing eight new MedTech customers who adopted its AI-powered traceability platform after moving away from legacy quality and product lifecycle systems.
Saile has raised $2.2 million in an oversubscribed pre-seed round led by Matchstick Ventures to improve healthcare staffing and credentialing. The platform uses AI agents to automate recruitment, onboarding, and compliance across various care settings.
EMA Wellness has formed an exclusive partnership with Mira Analytics to apply AI models for endpoint validation and rater surveillance in global central nervous system clinical trials, integrating these capabilities into EMAW's data platform.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
